PSMA, also known as folate hydrolase I (FOLH1) and glutamate carboxypeptidase II (GCPII), is a 750-aminoacid type II transmembrane glycoprotein which is 1000-fold overexpressed on the surface of prostate cancer cells. The gene discussed is FOLH1; the disease is prostate carcinoma.